Literature DB >> 16946442

Antidote use in the critically ill poisoned patient.

David P Betten1, Rais B Vohra, Matthew D Cook, Michael J Matteucci, Richard F Clark.   

Abstract

The proper use of antidotes in the intensive care setting when combined with appropriate general supportive care may reduce the morbidity and mortality associated with severe poisonings. The more commonly used antidotes that may be encountered in the intensive care unit (N-acetylcysteine, ethanol, fomepizole, physostigmine, naloxone, flumazenil, sodium bicarbonate, octreotide, pyridoxine, cyanide antidote kit, pralidoxime, atropine, digoxin immune Fab, glucagon, calcium gluconate and chloride, deferoxamine, phytonadione, botulism antitoxin, methylene blue, and Crotaline snake antivenom) are reviewed. Proper indications for their use and knowledge of the possible adverse effects accompanying antidotal therapy will allow the physician to appropriately manage the severely poisoned patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946442     DOI: 10.1177/0885066606290386

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  12 in total

1.  Structural perturbation of a dipalmitoylphosphatidylcholine (DPPC) bilayer by warfarin and its bolaamphiphilic analogue: A molecular dynamics study.

Authors:  Manuela Aseye Ayele Ayee; Charles William Roth; Belinda Sena Akpa
Journal:  J Colloid Interface Sci       Date:  2016-01-27       Impact factor: 8.128

2.  Nanodetoxification: emerging role of nanomaterials in drug intoxication treatment.

Authors:  Lauren M Graham; Thao M Nguyen; Sang Bok Lee
Journal:  Nanomedicine (Lond)       Date:  2011-07       Impact factor: 5.307

3.  Therapeutic approaches to delay the onset of Alzheimer's disease.

Authors:  Raj Kumar; Hani Atamna
Journal:  J Aging Res       Date:  2011-03-03

4.  Sweet and sour-a patient with life-threatening metabolic acidosis and acute renal failure.

Authors:  Robert Schorn; Robert Kalicki; Cornelius Remschmidt; Gunnar Schley; Niklaus Höfliger; Fabienne Aregger
Journal:  NDT Plus       Date:  2008-08-04

5.  Therapeutic effects of physostigmine during systemic inflammation.

Authors:  Katharina Effenberger-Neidnicht; Johannes Jägers; Rabea Verhaegh; Michael Kirsch
Journal:  J Inflamm Res       Date:  2018-12-07

Review 6.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

Review 7.  Antidotes for childhood toxidromes.

Authors:  Kam Lun Hon; Wun Fung Hui; Alexander Kc Leung
Journal:  Drugs Context       Date:  2021-06-02

Review 8.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

9.  Poisoning cases and their management in emergency centres of government hospitals in northwest Ethiopia.

Authors:  Getnet Mequanint Adinew; Asegedech Tsegaw Woredekal; Elizabeth L DeVos; Eshetie Melese Birru; Mohammed Birhan Abdulwahib
Journal:  Afr J Emerg Med       Date:  2017-04-20

Review 10.  Recent Bio-Advances in Metal-Organic Frameworks.

Authors:  Isobel Tibbetts; George E Kostakis
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.